Home » Topics » BioWorld Science

BioWorld Science
RSS

New rat model may shed light on mechanisms behind CSVD pathogenesis

March 17, 2022

TIMP-1 and CKM are biomarkers of treatment response in DMD

March 17, 2022

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics

March 17, 2022

New lysine-specific demethylase 5B inhibitors identified at FibroGen

March 17, 2022

Shengke Pharmaceuticals discovers FLT inhibitors

March 17, 2022

NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC

March 17, 2022

LinKinVax and GTP Bioways collaborate on second-generation pan-coronavirus vaccine

March 16, 2022

Study reports insights into organ-specific aging

March 16, 2022

Satellos advances compounds to modulate muscle stem cell polarity for Duchenne muscular dystrophy

March 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.